Fig. 1From: Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritisPersistence with oral bisphosphonates treatment by dosing frequency (a) and seropositive rheumatoid arthritis (b)Back to article page